Move by Biden administration could devastate intellectual property rights and life sciences research

Physicians need greater flexibility to achieve better health outcomes for their patients

Biopharmaceutical, biotech and medical technology companies comprise one of the state’s strongest sectors. They’re crucial to generating new jobs, products and services

The research capabilities of our universities are essential to the vitality of our innovation ecosystem and ability to continue to compete effectively

Major loophole in intellectual property protections threatens to stifle advances in life-saving medicines and treatments